Deutsche Bank AG Buys 167,918 Shares of Revvity, Inc. (NYSE:RVTY)

Deutsche Bank AG increased its stake in shares of Revvity, Inc. (NYSE:RVTY) by 43.9% in the fourth quarter, HoldingsChannel reports. The firm owned 550,614 shares of the company’s stock after buying an additional 167,918 shares during the period. Deutsche Bank AG’s holdings in Revvity were worth $61,454,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in the stock. Assetmark Inc. grew its position in shares of Revvity by 3,700.0% in the 4th quarter. Assetmark Inc. now owns 266 shares of the company’s stock worth $30,000 after buying an additional 259 shares during the last quarter. Optiver Holding B.V. purchased a new stake in shares of Revvity during the 4th quarter valued at $33,000. Quarry LP boosted its position in shares of Revvity by 45.7% in the 4th quarter. Quarry LP now owns 303 shares of the company’s stock worth $34,000 after purchasing an additional 95 shares in the last quarter. Millstone Evans Group LLC purchased a new position in Revvity during the 4th quarter worth $38,000. Finally, MassMutual Private Wealth & Trust FSB boosted its holdings in Revvity by 55.9% in the fourth quarter. MassMutual Private Wealth & Trust FSB now owns 385 shares of the company’s stock worth $43,000 after acquiring an additional 138 shares in the last quarter. Hedge funds and other institutional investors own 86.65% of the company’s stock.

Revvity Stock Up 8.1%

RVTY opened at $98.64 on Tuesday. The company has a fifty day moving average of $100.57 and a two-hundred day moving average of $110.96. The company has a debt-to-equity ratio of 0.41, a quick ratio of 3.03 and a current ratio of 3.60. Revvity, Inc. has a fifty-two week low of $88.53 and a fifty-two week high of $129.50. The stock has a market capitalization of $11.63 billion, a price-to-earnings ratio of 44.63, a PEG ratio of 3.82 and a beta of 1.02.

Revvity (NYSE:RVTY) last released its quarterly earnings results on Monday, April 28th. The company reported $1.01 earnings per share for the quarter, topping analysts’ consensus estimates of $0.96 by $0.05. The company had revenue of $664.76 million during the quarter, compared to analysts’ expectations of $662.30 million. Revvity had a return on equity of 7.68% and a net margin of 9.81%. Revvity’s quarterly revenue was up 2.3% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.98 EPS. On average, research analysts expect that Revvity, Inc. will post 4.94 earnings per share for the current year.

Revvity Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, August 8th. Investors of record on Friday, July 18th will be paid a $0.07 dividend. The ex-dividend date is Friday, July 18th. This represents a $0.28 dividend on an annualized basis and a yield of 0.28%. Revvity’s dividend payout ratio is currently 11.91%.

Wall Street Analyst Weigh In

Several research analysts have recently issued reports on RVTY shares. Robert W. Baird reduced their price objective on Revvity from $127.00 to $125.00 and set an “outperform” rating for the company in a research note on Tuesday, April 29th. KeyCorp raised their price target on shares of Revvity from $132.00 to $145.00 and gave the stock an “overweight” rating in a research report on Monday, February 3rd. The Goldman Sachs Group dropped their price objective on shares of Revvity from $140.00 to $125.00 and set a “buy” rating on the stock in a report on Tuesday, April 29th. JPMorgan Chase & Co. reduced their target price on shares of Revvity from $120.00 to $100.00 and set a “neutral” rating for the company in a report on Tuesday, April 29th. Finally, Barclays lowered their price target on shares of Revvity from $140.00 to $110.00 and set an “overweight” rating on the stock in a report on Thursday, April 10th. Four investment analysts have rated the stock with a hold rating, ten have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. According to MarketBeat, Revvity currently has an average rating of “Moderate Buy” and an average target price of $125.64.

Revvity Company Profile

Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.